Skip to main content
Year archive

Heidelberg Pharma AG — 2021 filings

All 47 regulatory filings released by Heidelberg Pharma AG (HPHA) in 2021, sourced directly from the official regulator.

47 Filings
2021 Period
2021 filings (47)
Filing Released Lang
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2021-10-29 English
Heidelberg Pharma Participates at Various Conferences
Regulatory Filings
2021-10-28 English
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements
2021-10-22 German
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements
2021-10-11 English
Q3 statement / Q3 financial report 2020/2021
Interim / Quarterly Report FY 2021
2021-10-11 English
Heidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2021
Interim / Quarterly Report 9M 2021
2021-10-07 English
Quartalsfinanzbericht
Interim / Quarterly Report 9M 2021
2021-10-07 German
Heidelberg Pharma AG Announces Adjustment of Guidance
Earnings Release FY 2021
2021-10-01 English
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements
2021-09-30 English
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements
2021-09-29 English
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements
2021-09-15 English
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements
2021-09-15 English
Heidelberg Pharma Announces Presentation at H.C. Wainwright 23rd Annual Global Investment Conference and Participation at Various Conferences
Regulatory Filings
2021-09-09 English
Heidelberg Pharma Provides Update on Phase I/IIa Clinical Trial with ATAC Candidate HDP-101 in the US
Regulatory Filings
2021-09-07 English
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements
2021-07-29 German
DGAP-DD: Heidelberg Pharma AG deutsch
Director's Dealing
2021-07-29 German
DGAP-DD: Heidelberg Pharma AG deutsch
Director's Dealing
2021-07-29 German
Paul Ehrlich Institute Allows Heidelberg Pharma to Start a Phase I/IIa Clinical Trial with ATAC Candidate HDP-101
Regulatory Filings
2021-07-19 English
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements
2021-07-19 English
Annual financial report 2019/2020
Annual Report FY 2020
2021-07-19 German
Q1 statement / Q1 financial report 2020/2021
Interim / Quarterly Report Q1 2021
2021-07-19 German
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements
2021-07-14 English
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements
2021-07-08 German
Heidelberg Pharma Reports on First Half-Year 2021
Earnings Release H1 2021
2021-07-08 English
Halbjahresfinanzbericht
Interim / Quarterly Report H1 2021
2021-07-08 German
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements
2021-06-24 English
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements
2021-06-21 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2021-06-17 English
Heidelberg Pharma Announces Participation at Various Conferences
Regulatory Filings
2021-06-17 English
Heidelberg Pharma AG Raises EUR 20 Million From Private Placement
Share Issue/Capital Change
2021-06-15 English
Heidelberg Pharma AG to Raise Capital in a Private Placement
Share Issue/Capital Change
2021-06-15 English
Heidelberg Pharma AG: Annual General Meeting 2021 of Heidelberg Pharma Approves All Proposed Resolutions
AGM Information
2021-05-18 English
Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2021
Interim / Quarterly Report Q1 2021
2021-04-29 English
Quartalsfinanzbericht
Interim / Quarterly Report Q1 2021
2021-04-29 German
Jahres- und Konzernabschluss zum Geschäftsjahr vom 01.12.2019 bis zum 30.11.2020
Annual Report FY 2020
2021-04-26 German
Heidelberg Pharma AG: Bekanntmachung der Einberufung zur Hauptversammlung am 18.05.2021 in Ladenburg mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information
2021-04-09 German
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2021-03-31 English
Heidelberg Pharma to Present New Data on its Proprietary ATAC Technology Platform at the AACR Annual Meeting 2021
Investor Presentation
2021-03-31 English
Heidelberg Pharma announces financial figures for fiscal year 2020 and provides business update
Earnings Release FY 2020
2021-03-25 English
Heidelberg Pharma AG Secures Financing Commitment From its Main Shareholder dievini
Capital/Financing Update
2021-03-19 English
Heidelberg Pharma Expands Management Team
Board/Management Information
2021-03-01 English
Heidelberg Pharma and Indiana University Publish Results on HER2-ATAC for Targeted Immunotherapy of Triple Negative Breast Cancer in Science Translational Medicine
Environmental & Social Information
2021-02-11 English
Heidelberg Pharma AG: FDA Allows Heidelberg Pharma to Start a Phase I/IIa Clinical Trial with ATAC Candidate HDP-101
Regulatory Filings
2021-02-04 English
Report Publication Announcement 2021
Report Publication Announcement
2021-01-13 English
Hinweis auf Jahresfinanzbericht vom 01.12.2019 bis zum 30.11.2020
Report Publication Announcement
2021-01-13 German
Hinweis auf Halbjahresfinanzbericht vom 01.12.2020 bis zum 31.05.2021
Report Publication Announcement
2021-01-13 German
Hinweis auf Jahresfinanzbericht vom 01.12.2019 bis zum 30.11.2020
Report Publication Announcement
2021-01-13 German